Airway Diseases


Ectoin® Isotonic Inhalation Solution

Isotonic Solution for effective protection and moisturization of the lungs

Claims

Inhalation solution for supportive treatment to reduce inflammation of the airways in case of bronchitis, asthma or Chronic Obstructive Pulmonary Disease (COPD).

  • For supportive treatment and symptom alleviation of diseases of the airways, such as allergic or non-allergic asthma, or Chronic Obstructive Pulmonary Disease (COPD).
  • For supportive treatment and prevention of bronchitis symptoms.
  • Protects and moisturizes the mucosa of the airways (e. g. when exposed to particulate matter, pollen, dust or to dry air in heated or air conditioned rooms).

     

  • Prevents symptoms of allergic reactions of the respiratory system while suffering from e. g. allergic asthma, house-dust allergy, etc.

Ingredients

Ectoin®, Sea Salt, Water.

Suitable for

Newborn, infants, children, adolescents and adults.

Dosage Forms

Single-dose units with 2.5 ml solution for jet, mesh, or ultrasound nebulizers

 Study Overview

Unfried et. al., 2010; Sydlik et. al., 2013; Unfried et. al., 2014; Unfried et. al., 2016

  • Tested in patients with acute infection of the respiratory system, asthma and bronchitis.
  • Proven reduction of lung inflammation due to lifelong exposure to environmental air pollution.
  • Several preclinical and clinical studies prove significant reduction of inflammation markers after treatment with Ectoin®.

Status (EU): Medical Device Class IIa